(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

Oct 25, 2017 7:00 AM - Oct 27, 2017 3:00 PM

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

DIA/FDA Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

Back to Agenda

Session 5: Keynote Address

Session Chair(s)

James Wild, PhD

James Wild, PhD

Pharmacologist, CDER

FDA, United States

Session 5: Keynote Address

Speaker(s)

James D. Thompson, PhD

Session Co-Chair

James D. Thompson, PhD

Moderna Therapeutics , United States

CMC Therapeutic Area Lead

Philip (P.J.) Brooks, PhD

Keynote

Philip (P.J.) Brooks, PhD

National Center for Advancing Translational Sciences (NCATS), NIH, United States

Deputy Director, Division of Rare Diseases Research Innovation

Arthur M. Krieg, MD

Speaker

Arthur M. Krieg, MD

Checkmate Pharmaceuticals, United States

CEO and CSO

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.